Skip Ribbon Commands
Skip to main content
Menu
Dr Lawrence Ng Cheng Kiat

Dr Ng Lawrence Cheng Kiat

​MD, MRCP (UK)

Consultant

Singapore General Hospital

Specialty: Haematology

Sub-specialties: Lymphoma, Myeloma

Conditions Treated by this Doctor:
Acute Lymphocytic Leukemia (ALL), Aplastic Anaemia, Chronic lymphocytic leukemia, Chronic Myeloid Leukemia (CML), Deep Vein Thrombosis, Deep Vein Thrombosis, essential thrombocythemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myelofibrosis, Polycythemia Vera, Thalassaemia.

Clinical Appointments

  • Consultant SingHealth Duke-NUS Blood Cancer Centre
  • Consultant Haematology Singapore General HospitalSingapore General Hospital
  • Consultant National Cancer Centre SingaporeNational Cancer Centre Singapore

Profile

​Dr Lawrence Ng obtained his medical degree in 2010 from Malaysia. He started Internal Medicine residency training in 2013 and obtained MRCP from Royal College of Physician London in 2015. He started Haematology specialty training in 2016 and qualified as haematologist in 2019. He is actively involved in clinical services, clinical trials, and education. His areas of interest are lymphoma and haematopoietic stem cell transplantation.

Education

Professional Appointments and Committee Memberships

  • ​Clinical Physician Faculty Member (Haematology)
  • Clinical Tutor – Yong Loo Lin School of Medicine, NUS
  • Clinical Tutor – Duke-NUS Medical School
  • Associate in Education (College of Clinical Medicine)


Awards

  • ​Singhealth Health Quality Service HERO Awards 2021
  • Service with a Heart 2019


Research Interests

Publications

  • ​Lawrence, Ng & Christopher, Tham & Francesca, Lim & Yunxin, Chen & Shin, Ong & Chandramouli, Nagarajan & Jing, Lee & Yeow, Goh & Yeh, Linn & Yuh, Lee & Colin, Phipps & Jeffrey, Quek & Than, Hein & Jordan, Hwang & Nicholas, Grigoropoulos & William, Hwang & Aloysius, Ho. (2021). Hematopoetic stem cell transplant in aggressive T and NK/T cell lymphoma - Role of upfront autologous transplant in nodal peripheral T-cell lymphoma. Blood Cell Therapy.
  • Ong, Shin & de Mel, Sanjay & Grigoropoulos, Nicholas & Chen, Yunxin & Tan, Yan & Tan, Melinda & Ng, Lawrence & Lee, Yuh & Phipps, Colin & Goh, Yeow & Yong, Kar & Liu, Xin & Chng, Wee & Lim, Soon & Nagarajan, Chandramouli. (2021). High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma. Blood Cancer Journal. 11. 10.1038/s41408-021-00535-y.
  • Phipps, Colin & Nagarajan, Chandramouli & Ng, Lawrence & Chua, Jane & Chen, Yunxin & Ong, Shin & Tan, Melinda & Grigoropoulos, Nicholas & Gopalakrishnan, Sathish & Ng, Heng & Hwang, William & Goh, Yeow & Lee, Yuh. (2020). Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide. Blood. 136. 25-26. 10.1182/blood-2020-142275.
  • Jaya-Bodestyne, Sandra & Lee, Lai & Tan, Lay-Kok & Tan, Kok Hian & Østbye, Truls & Malhotra, Rahul & Allen, John & Tan, Sophie & Tan, Melinda & Ng, Lawrence & Yong, Yang & Tan, Thiam Chye. (2020). Risk factors for pregnancy-associated venous thromboembolism in Singapore. Journal of perinatal medicine. -1. 10.1515/jpm-2020-0298.
  • Chuen Wen, Tan & Wong, Wan & Cheen, Mcvin & Chu, Yvonne & Lim, Shan & Ng, Lawrence & Yeo, Dillon & Morvil, Gayathry & Lee, Lai & Ng, Heng. (2020). Assessment of aPTT-based clot waveform analysis for the detection of haemostatic changes in different types of infections. Scientific Reports. 10. 14186. 10.1038/s41598-020-71063-1.


Research Trials